Good morning, everyone, and nice to see you today. The heat continues to rise over the Pharmalot corporate campus, where we are trying to keep cool by downing another hot cup of stimulation. You know the drill - grab one yourself or reach for a bottle of water, if you prefer. Meanwhile, we would like to invite you to join us for a July 27 webinar on using analytics to improve clinical trial efficiency. And now, here are some tidbits. Hope your day goes well and stay cool...
Pfizer Will Not Break Up Animal Health Unit (Bloomberg News)
Roche Raises Profit Forecast As Cost Cutting Kicks In (Bloomberg News)
J&J Suppliers Will Need Sustainability Goals (InPharma Technologist)
Doctors Are Writing Fewer Prescriptions For Niaspan (Chicago Tribune)
Roche To Buy MTM Laboratories (Irish Times)
ICON Will Take Staff But Not Facilities In Deal With Pfizer (Outsourcing Pharma)
Dynavax Stock Plunges On Hepatitis B Study Results (Associated Press)
EDITOR'S NOTE: Please check this post for updates throughout the morning
1 Comment
The AZ Brilinta piece is a non-story. They're not doing a confirmatory trial for PLATO because FDA isn't forcing them to do so. End of non-story.